VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,534,709 | -14.6% | 3,467,156 | 0.0% | 3.00% | -17.7% |
| Q2 2023 | $55,647,854 | +106.8% | 3,467,156 | 0.0% | 3.64% | +111.8% |
| Q1 2023 | $26,905,131 | -56.3% | 3,467,156 | +9.0% | 1.72% | -52.9% |
| Q4 2022 | $61,560,903 | -9.2% | 3,181,442 | 0.0% | 3.65% | -7.4% |
| Q3 2022 | $67,797,000 | +56.6% | 3,181,442 | 0.0% | 3.94% | +9.4% |
| Q2 2022 | $43,299,000 | -42.1% | 3,181,442 | 0.0% | 3.61% | -36.4% |
| Q1 2022 | $74,732,000 | -4.0% | 3,181,442 | +9.1% | 5.67% | +24.7% |
| Q4 2021 | $77,883,000 | +54.0% | 2,914,776 | 0.0% | 4.55% | +51.9% |
| Q3 2021 | $50,571,000 | +30.8% | 2,914,776 | 0.0% | 3.00% | +34.4% |
| Q2 2021 | $38,650,000 | – | 2,914,776 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |